LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Tags
HPLC
Consumables
Columns
LC/MS
LC/HRMS
LC/MS/MS
LinkedIn Logo

Method Development and Optimization of Native RPLC-HRMS Characterization of ADCs using Biozen Native RP Columns

RECORD | Already taken place We, 29.10.2025
Learn how to develop and optimize native RPLC-HRMS methods for ADC characterization. Explore DAR analysis, isomer separation, and MS-friendly workflows using Biozen Native RP columns.
Go to the webinar
Phenomenex: Method Development and Optimization of Native RPLC-HRMS Characterization of ADCs using Biozen Native RP Columns
Phenomenex: Method Development and Optimization of Native RPLC-HRMS Characterization of ADCs using Biozen Native RP Columns
During this presention, we will review the following:
  • An RPLC-HRMS method development approach for rapid, comprehensive DAR analysis, including positional isomers, under native conditions.
  • Sorbent polarity and hydrophobicity effects on retention and selectivity of individual DAR species.
  • Optimized chromatographic separation and MS identification of all DAR species, including positional isomers, of several ADCs.

Key Learning Points

  • Learn about method development approach for native RPLC-HRMS of ADCs using Biozen Native RP columns.
  • Take a deep dive into method optimization strategies.
  • Examine online HRMS identification of individual DAR species.

Who Should Attend

  • Characterization and In-process scientists needing to develop robust, MS friendly methods to characterize and identify individual DAR species, including positional isomers, and average drug to antibody ratios (DAR) of antibody drug conjugates (ADCs).

Speaker: Carl Sanchez (Principal Scientific Advisor, Phenomenex)

Carl Sanchez is a Principal Scientific Advisor in Phenomenex R&D where he provides subject matter expertise and advanced technical problem-solving support to Phenomenex businesses and customers. Additionally, Carl is actively involved in new product development projects spanning HPLC, sample preparation and GC. Carl has authored multiple papers on HPLC in peer reviewed journals as well as given over 100 lectures at scientific conferences worldwide. Carl’s current research interests include LC-MS characterization of biotherapeutics.

Phenomenex
LinkedIn Logo
 

Related content

Analysis of Anti-Degradant Additive (6PPD) and its Transformation Product 6PPD-Quinone in Tire Rubber Using an Integrated HPLC System

Applications
| 2026 | Shimadzu
Instrumentation
HPLC
Manufacturer
Shimadzu
Industries
Energy & Chemicals

Performance Evaluation of Microbial Identification Using a Benchtop MALDI-TOF MS

Applications
| 2026 | Shimadzu
Instrumentation
MALDI, LC/MS, LC/TOF, Software
Manufacturer
Shimadzu
Industries
Pharma & Biopharma, Food & Agriculture

Achieving Sharp Peaks and High Sensitivity with Nexera X4

Applications
| 2026 | Shimadzu
Instrumentation
HPLC
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Achieving Solvent Reduction and Lower Running Costs with Nexera X4

Applications
| 2026 | Shimadzu
Instrumentation
HPLC, Consumables, LC columns
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Maximizing Operational Productivity through Ultra-Fast Analysis with Nexera X4

Applications
| 2026 | Shimadzu
Instrumentation
HPLC
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike